Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Radboud University Medical Center
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
National Cancer Centre, Singapore
Peking Union Medical College Hospital
Moonlight Bio, Inc
Vanderbilt-Ingram Cancer Center
University Hospital, Toulouse
Mayo Clinic
Assiut University
National Institute of Cardiology, Warsaw, Poland
Cancer Research UK
University Hospital, Rouen
University Health Network, Toronto
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Hospices Civils de Lyon
West China Hospital
First Affiliated Hospital of Zhejiang University
Başakşehir Çam & Sakura City Hospital
West China Hospital
GCS Ramsay Santé pour l'Enseignement et la Recherche
Hospices Civils de Lyon
AccSalus Biosciences, Inc.
Central Hospital, Nancy, France
Latin American Cooperative Oncology Group
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Sun Yat-sen University
National Health Research Institutes, Taiwan
Fujian Medical University
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Beijing GoBroad Hospital
Xijing Hospital
National Cancer Center, Korea
University Medical Center Groningen
National Cancer Center, Korea
Beijing GoBroad Hospital
Sun Yat-sen University
Hansoh BioMedical R&D Company
Guangdong Provincial People's Hospital
University of Pisa
National Taiwan University Hospital
West China Hospital
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Beijing Chest Hospital
Chulalongkorn University
Zhejiang Chinese Medical University
Imperial College London